This inventor holds 3 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1976-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JA (1976)
- Toyonaka, JA (1977)
- Sakura, JP (1989)
Company Filing History:
Years Active: 1976-1989
Title: Hideo Yagi: Innovator in Concrete and Pharmaceutical Processes
Introduction
Hideo Yagi is a notable inventor based in Osaka, Japan. He has made significant contributions to the fields of concrete technology and pharmaceuticals. With a total of 3 patents, Yagi's work reflects his commitment to innovation and improvement in these industries.
Latest Patents
Yagi's latest patents include a concrete admixture designed to enhance the flowability and air-entraining properties of fresh concrete. This invention aims to improve the quality and performance of concrete in various applications. Another significant patent is the process for the optical resolution of DL-2-(4-hydroxyphenyl)glycine. This process involves treating DL-2-(4-hydroxyphenyl)glycine with d-3-bromo-2-oxo-10-bornanesulfonic acid to create a mixture of salts. The method utilizes specific solvents to isolate and recover the desired compounds effectively.
Career Highlights
Hideo Yagi is currently employed at Fujisawa Pharmaceutical Company, Ltd. His work at this esteemed organization has allowed him to collaborate on various innovative projects that contribute to advancements in pharmaceutical sciences.
Collaborations
Yagi has worked alongside talented colleagues such as Kazuhiko Yoshida and Toru Takeuchi. Their combined expertise has fostered a collaborative environment that encourages innovation and the development of new technologies.
Conclusion
Hideo Yagi's contributions to concrete technology and pharmaceuticals demonstrate his innovative spirit and dedication to improving industry standards. His patents reflect a deep understanding of both materials and processes, making him a valuable asset in his field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile